Policyholder Services

Is chelation therapy for treatment of band keratopathy permitted under Surgery Class 1 coverage?

Yes. Calcific band keratopathy is a degeneration of the superficial corneal characterized by a linear band of calcium or urates deposited across the cornea. The condition can be caused by chronic inflammatory ocular disease, kidney disease, gout, or other conditions that result in high levels of calcium in the body. Chelation therapy is an effective treatment to remove the calcium deposits by applying an ethylenediamine-tetraacetic acid (EDTA) solution and superficially scraping the corneal surface. Before undergoing chelation treatment, patients should undergo a workup to rule out associated metabolic or renal disease, and underlying conditions should be treated or controlled as much as possible.

Please refer to OMIC's Copyright and Disclaimer regarding the contents on this website

Leave a comment

Six reasons OMIC is the best choice for ophthalmologists in America.

Consistent return of premium.

Publicly-traded insurance companies exist to make profits for shareholders while physician-owned carriers often return profits to their policyholders. Don’t underestimate this benefit; it can add up to tens of thousands of dollars over the course of your career. OMIC has one of the most generous dividend programs for ophthalmologists and has returned more than $90 Million to our members through dividends.